ImportantUpdates
SPARC received ~₹1500 Cr from Shanghvi Finance for a preferential allotment of 3.85 Cr warrants.
Sun Pharma Advanced Research Company LimitedSPARC · Filed with the exchange
This significant capital infusion boosts SPARC's financial strength, paving the way for future strategic advancements.
No comments yet. Be the first.